0000950170-24-040164.txt : 20240402
0000950170-24-040164.hdr.sgml : 20240402
20240402161516
ACCESSION NUMBER: 0000950170-24-040164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240329
FILED AS OF DATE: 20240402
DATE AS OF CHANGE: 20240402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tucker John H
CENTRAL INDEX KEY: 0001303480
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38293
FILM NUMBER: 24814372
MAIL ADDRESS:
STREET 1: INDEVUS PHARMACEUTICALS, INC.
STREET 2: 99 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: scPharmaceuticals Inc.
CENTRAL INDEX KEY: 0001604950
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 465184075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25 BURLINGTON MALL ROAD, SUITE 203
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 617-517-0730
MAIL ADDRESS:
STREET 1: 25 BURLINGTON MALL ROAD, SUITE 203
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
ownership.xml
4
X0508
4
2024-03-29
0001604950
scPharmaceuticals Inc.
SCPH
0001303480
Tucker John H
C/O SCPHARMACEUTICALS INC.
25 BURLINGTON MALL ROAD, SUITE 203
BURLINGTON
MA
01803
true
true
false
false
President and CEO
false
Stock Option (right to buy)
7.06
2024-03-29
4
A
false
56025
0
A
2031-01-25
Common Stock
56025
56025
D
On January 25, 2021, the Reporting Person was granted 112,050 options which were eligible to vest and become exercisable subject to certain performance conditions. On March 29, 2024, the Issuer's Board of Directors determined that the performance conditions for one half (1/2) of the grant were met, resulting in the vesting of 56,025 shares. The remaining 56,025 options were previously forfeited due to failure to meet certain performance conditions.
/s/ John H. Tucker
2024-04-02